Cumberland Pharmaceuticals Inc. (CPIX) — Analyst outlook / Analyst consensus target is. Based on 5 analyst ratings, the consensus is bullish — 3 Buy, 2 Hold.
Analysts estimate Earnings Per Share (EPS) of $-0.23 and revenue of $0.05B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.46 vs est $-0.23 (missed -100%). Analyst accuracy: 50%.
CPIX Analyst Ratings
Buy
Based on 5 analysts giving stock ratings to Cumberland Pharmaceuticals Inc. in the past 3 months
EPS Estimates — CPIX
50%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024
Actual –$0.46
vs Est –$0.23
▼ 50.0% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — CPIX
82%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2024
Actual $0.038B
vs Est $0.045B
▼ 18.4% off
Revenue Trend
Analysts expect stable revenue going forward.
